Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    22983573 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Condition: Sickle Cell Disease
Intervention: Other: SCD Group
2 Terminated
Has Results
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Conditions: Sickle Cell Disease;   Pulmonary Hypertension
Interventions: Drug: Sildenafil;   Drug: Placebo
3 Active, not recruiting Decision Aid for Therapeutic Options In Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   Hemoglobin SS;   Hemoglobin SC;   Hemoglobin Beta Thalassemia
Interventions: Other: Decision Aid;   Other: Standard Practice

Study has passed its completion date and status has not been verified in more than two years.